Association of oral bisphosphonates with cardioembolic ischemic stroke: a nested case-control study

Conclusion: The use of oral bisphosphonates increases specifically the odds of cardioembolic IS, in a duration-dependent manner, while leaves materially unaffected the odds of non-cardioembolic IS.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research